￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Lecanemab-LEQEMBI treatment cost, medical insurance and self-payment information

2026-02-01 22:25:32

Check Details
Description of golodirsen’s domestic and overseas launch time and clinical availability channels

2026-02-01 22:25:32

Check Details
Analysis of the treatment schedule, usage and dosage and clinical use guidelines of Vidicitomab (Aidexi)

2026-02-01 22:25:32

Check Details
Isatuximab (Isatuximab) price, market reference and analysis of drug purchase channels in various regions

2026-02-01 22:25:32

Check Details
Analysis of the targeted mechanism of action, indications and clinical efficacy of caposetinib tablets

2026-02-01 22:25:32

Check Details
Analysis of domestic and overseas marketing status, clinical progress and R&D dynamics of Guselkumab

2026-02-01 22:25:32

Check Details
Application and efficacy evaluation of tenapano (Ventile) combination therapy

2026-02-01 22:25:32

Check Details
How much does Lapatinib cost per month?

2026-02-01 22:25:32

Check Details
Is filgotinib already on the market in the country? What is the situation?

2026-02-01 22:25:32

Check Details
What diseases is Trientine mainly used to treat?

2026-02-01 22:25:32

Check Details
Analysis of whether mirikizumab has been launched in China

2026-02-01 22:25:32

Check Details
Selumetinib/Coselumab approved for neurofibromatosis type 1 in adults with plexiform neurofibromas

2026-02-01 22:25:32

Check Details
Category
相关知识